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For decades anal inflammation, a common problem in patients
with inflammatory bowel disease (IBD), has been suspected to
predispose for anal squamous cell carcinoma (SCC) (Brofeldt,
1927). We previously examined the risk of anal SCC among
patients with haemorrhoids, fissures, fistulae, or abscesses and
failed to support a causal relationship up to 13 years after those
benign anal lesions (Frisch et al, 1994). Also, no convincing assoc-
iation was seen between IBD and the risk of anal SCC in the only
case-control study addressing the question (Frisch et al, 1998).
Using Danish health registers, we generate a population-based
estimate of the incidence of anal SCC in patients with IBD and
compare this estimate with the incidence of anal SCC in the
general population.
MATERIAL AND METHODS
We identified 9875 Danish patients with valid personal identifiers
who were hospitalized during the period 1977–1989 with a diag-
nosis of either Crohn’s disease (ICD8: 563.01) or ulcerative colitis
(ICD8: 563.19). Forty-one patients with polyposis coli (ICD8:
211.36) and 232 patients who died during the first hospitalization
for IBD were excluded, leaving 9602 IBD patients for follow-up.
We assessed the risk of anal SCC among patients with unam-
biguous diagnoses of either Crohn’s disease (1067 men, 1656
women) or ulcerative colitis (2988 men, 3346 women). To
evaluate the overall risk of anal SCC among IBD patients, we
combined the two cohorts and included an additional 505 patients
registered with both Crohn’s disease and ulcerative colitis, and 40
patients with both Crohn’s disease and proctitis (ICD8: 569.04).
Person-years were counted from the date of first hospital
discharge after the cohort defining IBD until anal SCC, death, or
January 1, 1995, whichever came first. Expected incidence rates of
anal SCC were calculated as weighed population incidence rates
of anal SCC (Frisch et al, 1993), with weights reflecting the
gender, age, and calendar period composition of the IBD cohorts.
Observed incidence rates were calculated directly as the observed
number of anal SCCs divided by the person-years. Ratios of
observed to expected anal SCC incidence per 100 000 person-
years (with 95% confidence intervals (CIs)) estimated relative risk
(RR).
RESULTS
2723 Crohn’s disease patients were followed 27 647 person-years
for anal SCC; mean follow-up = 10.2 (range 0–18) years. Mean
age at first hospitalization was 39.9 years. Fifteen years after her
first registered hospitalization for Crohn’s disease and 41 years
after a cervical cancer, one woman developed anal SCC at age 80
years (observed incidence = 3.62 per 100 000, expected inci-
dence = 1.21 per 100 000, RR = 3.0; 95% CI: 0.0–16.7).
6334 ulcerative colitis patients were followed 65 281 person-
years; mean follow-up = 10.3 (range 0–18) years. Mean age at first
hospitalization was 43.1 years. One woman developed anal SCC at
age 75 years, 16 years after her first registered hospitalization
for ulcerative colitis (observed incidence = 1.53 per 100 000,
expected incidence = 1.34 per 100 000, RR = 1.1; 95% CI:
0.0–6.4).
The combined cohort of 9602 IBD patients was followed for
99 229 person-years. Only the two patients mentioned above
developed anal SCC (RR = 1.6; 95% CI: 0.2–5.7).
DISCUSSION
The two cases of anal SCC occurred 15 and 16 years after the
onset of IBD symptoms. If inflammatory bowel diseases play a
causal role in a few cases of anal SCC, this may be restricted to
patients with long-standing Crohn’s disease or ulcerative colitis.
Although we followed a large cohort of patients for up to 18 years,
few patients had follow-up periods longer than 15 years.
Consequently, our data do not exclude a long-term effect (Connell
et al, 1994).
In the general Danish population, anal SCCs occur at an
incidence of around 0.5–1.0 per 100 000 person-years (Frisch et
al, 1993). Our observation of two anal SCCs during approximately 
Short communication
Anal carcinoma in inflammatory bowel disease
M Frisch1 and C Johansen2
1 Department of Epidemiology Research, Danish Epidemiology Science Centre, Statens Serum Institut, 5 Artillerivej, DK-2300 Copenhagen, Denmark; 2Danish
Cancer Society, Institute of Cancer Epidemiology, 49 Strandboulevarden, DK-2100 Copenhagen, Denmark.
Summary We followed 9602 patients with Crohn’s disease or ulcerative colitis for anal squamous cell carcinoma for up to 18 years. No
significant increase was observed: two cases occurred vs 1.3 expected during 99 229 person-years of observation, (standardized incidence
ratio = 1.6; 95 confidence interval: 0.2–5.7). Anal squamous cell carcinoma is rare even in inflammatory bowel disease. © 2000 Cancer
Research Campaign
Keywords: anus neoplasms; ulcerative colitis; Crohn’s disease; inflammatory bowel disease; cohort studies
89
Received 4 January 2000
Revised 7 February 2000
Accepted 7 February 2000
Correspondence to: M Frisch
British Journal of Cancer (2000) 83(1), 89–90
© 2000 Cancer Research Campaign
doi: 10.1054/ bjoc.2000.1153, available online at http://www.idealibrary.com on 99 000 person-years suggests a slightly increased risk of anal
SCC in IBD patients with disease of long duration. However, with
an incidence of approximately one case of anal SCC per 5000
inflammatory bowel disease patients followed for 10 years, anal
SCC is a rare and not significantly increased malignancy even in
this group.
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